Transferring patients from methadone to buprenorphine: the feasibility and evaluation of practice guidelines. Buprenorphine‐mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives. Mannelli P, Peindl K, Lee T, Bhatia KS, Wu LT. Woden: Australian National Council on Drugs, 2001. The effectiveness of interventions for illicit drug use. Gowing L, Proudfoot H, Henry‐Edwards S, Teeson M.
Canberra: Australian Department of Health and Ageing, National Drug Strategy, 2014. National Guidelines for Medication‐assisted Treatment of Opioid Dependence.
Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N.
#A opiate withdrawl diarie professional
Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs. The use of buprenorphine to manage withdrawal then allows the individual to continue on this highly effective treatment.īuprenorphine opioid dependence opioid withdrawal precipitated withdrawal treatment.
This demonstrates that rapid increases in buprenorphine dose can be used as an effective treatment for buprenorphine-induced precipitated opioid withdrawal. In our case, a patient developed a significant precipitated opioid withdrawal following buprenorphine administration, and was able to be successfully treated in hospital with further buprenorphine. There is little documented experience regarding the management of precipitated withdrawal. The pharmacology of buprenorphine increases the risk of a precipitated opioid withdrawal when commencing patients on buprenorphine treatment, particularly when transferring from long acting opioids (e.g. Buprenorphine is a partial opioid agonist commonly used to treat opioid dependence.
0 kommentar(er)
